Cases in kids and teens dropped 99% after the CDC recommended universal vaccination at birth.September 11, 2025Check out STAT+Sponsored By Erskine Palmer/CDC Dropping hepatitis B shots for newborns would ignore history and endanger children, scientists warn Critics of newborn hepatitis B shots overlook why the CDC adopted the policy, and how cases dropped 99% after universal vaccination began By Eric Boodman STAT+ | Fifty cancer types in one liquid biopsy test: Exact Sciences enters early-detection market Liquid biopsy test Cancerguard can scan for 50 cancers in one blood sample. The company says it marks a new era in early detection, but there are caveats. By Angus Chen STAT+ | Psychedelics are suddenly drawing interest from big drugmakers AbbVie's $1.2 billion deal signals pharma's new embrace of psychedelics, with Compass, J&J, and Otsuka all circling the space for future deals By Olivia Goldhill Jenny Kane/AP Opinion: The MAHA kids' health report missed an important opportunity on children and non-sugar sweeteners Aspartame, sucralose, and stevia pervade children's diets, yet their health effects are poorly understood and rarely discussed, experts write. By Allison Sylvetsky and Priya Fielding-Singh STAT+ | Child dies after receiving new experimental gene therapy The treatment by Capsida Biotherapeutics was designed to treat STXBP1 encephalopathy By Jason Mast STAT+ | Piercing the hype around Patrick Soon-Shiong's 'Bioshield' cancer treatment In this week's edition of "Adam's Biotech Scorecard," a closer look at the claims made recently by the biotech company ImmunityBio. By Adam Feuerstein Trump, Chinese biotech, and an industry career reshaped by illness This week on the podcast, we discuss Trump's potential crackdown on drugs invented in China and the industry reaction. By Adam Feuerstein, Elaine Chen, and Allison DeAngelis Opinion: Ebola outbreak in the Democratic Republic of Congo is a warning A decade ago, the U.S. would have been instrumental in containing an Ebola outbreak in the DRC. So much has changed. By Krutika Kuppalli More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments